Table 2: Patients clinical character characteristics.
Patient ID | Infection time (days after surgery) | Bacteria cultured | Antibiotics (IV/days) | Discharge medications 6 months | VSD change times | VSD duration (days) | Time to dry wound (days) | Reoperation | Skin necrosis/blistering |
1 | 42 | Staphylococcus aureus | Vancomycin/20 | Rifampicin | 2 | 20 | 22 | NO | NO |
2 | 45 | Staphylococcus aureus | Vancomycin/22 | Rifampicin | 2 | 22 | 24 | NO | NO |
3 | 48 | Staphylococcus aureus | Vancomycin/21 | Rifampicin | 2 | 21 | 23 | NO | NO |
4 | 44 | Staphylococcus aureus | Vancomycin/26 | Rifampicin | 3 | 26 | 28 | NO | NO |
5 | 40 | Staphylococcus aureus | Vancomycin/22 | Rifampicin | 2 | 22 | 23 | NO | NO |
6 | 50 | Staphylococcus aureus | Vancomycin/20 | Rifampicin | 2 | 20 | 22 | NO | NO |
7 | 35 | Staphylococcus epidermidis | Vancomycin/22 | Rifampicin | 2 | 22 | 24 | NO | NO |
8 | 62 | Staphylococcus aureus | Vancomycin/27 | Rifampicin | 3 | 27 | 29 | NO | NO |
9 | 30 | Staphylococcus aureus | Vancomycin/21 | Rifampicin | 2 | 21 | 23 | NO | NO |
10 | 28 | Staphylococcus epidermidis | Vancomycin/21 | Rifampicin | 2 | 21 | 24 | NO | NO |
11 | 57 | Staphylococcus aureus | Vancomycin/25 | Rifampicin | 2 | 22 | 25 | NO | NO |
12 | 64 | Staphylococcus aureus | Vancomycin/23 | Rifampicin | 2 | 21 | 23 | NO | NO |
13 | 39 | Staphylococcus epidermidis | Vancomycin/21 | Rifampicin | 2 | 21 | 24 | NO | NO |
14 | 25 | Staphylococcus aureus | Vancomycin/27 | Rifampicin | 3 | 27 | 29 | NO | NO |
15 | 37 | Staphylococcus aureus | Vancomycin/26 | Rifampicin | 3 | 26 | 27 | NO | NO |
16 | 32 | Staphylococcus aureus | Vancomycin/27 | Rifampicin | 3 | 27 | 29 | NO | NO |